The clinical trials in the initial five-year award period of the Asthma Clinical Research Network

被引:7
作者
Chinchilli, VM
Drazen, JM
Fish, JE
Lemanske, RF
Lazarus, SC
Martin, RJ
机构
[1] Penn State Univ, Coll Med, Dept Hlth Evaluat Sci, Hershey, PA 17033 USA
[2] Brigham & Womens Hosp, Div Resp, Boston, MA 02115 USA
[3] Thomas Jefferson Med Coll, Philadelphia, PA USA
[4] Univ Wisconsin, Madison, WI USA
[5] Univ Calif San Francisco, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA
[6] Natl Jewish Med & Res Ctr, Denver, CO USA
来源
CONTROLLED CLINICAL TRIALS | 2001年 / 22卷 / 06期
关键词
beta-agonists; lung function measurements; inhaled corticosteroids; treatment failure; plasma cortisol measurements;
D O I
10.1016/S0197-2456(01)00160-X
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
During its first years of existence, the Asthma Clinical Research Network initiated four major clinical trials and one pilot clinical trial. The objective of this article is to describe briefly the specific aims, design, and conduct of those five trials. (C) Elsevier Science Inc. 2001.
引用
收藏
页码:126S / 134S
页数:9
相关论文
共 17 条
[1]   RAPID ONSET OF TOLERANCE TO THE BRONCHOPROTECTIVE EFFECT OF SALMETEROL [J].
BHAGAT, R ;
KALRA, S ;
SWYSTUN, VA ;
COCKCROFT, DW .
CHEST, 1995, 108 (05) :1235-1239
[2]   INTERACTION OF INHALED BETA(2) AGONIST AND INHALED CORTICOSTEROID ON AIRWAY RESPONSIVENESS TO ALLERGEN AND METHACHOLINE [J].
COCKCROFT, DW ;
SWYSTUN, VA ;
BHAGAT, R .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1995, 152 (05) :1485-1489
[3]   REGULAR USE OF INHALED ALBUTEROL AND THE ALLERGEN-INDUCED LATE ASTHMATIC RESPONSE [J].
COCKCROFT, DW ;
OBYRNE, PM ;
SWYSTUN, VA ;
BHAGAT, R .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1995, 96 (01) :44-49
[4]   REGULAR INHALED SALBUTAMOL AND AIRWAY RESPONSIVENESS TO ALLERGEN [J].
COCKCROFT, DW ;
MCPARLAND, CP ;
BRITTO, SA ;
SWYSTUN, VA ;
RUTHERFORD, BC .
LANCET, 1993, 342 (8875) :833-837
[5]   Comparison of regularly scheduled with as-needed use of albuterol in mild asthma [J].
Drazen, JM ;
Israel, E ;
Boushey, HA ;
Chinchilli, VM ;
Fahy, JV ;
Fish, JE ;
Lazarus, SC ;
Lemanske, RF ;
Martin, RJ ;
Peters, SP ;
Sorkness, C ;
Szefler, SJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (12) :841-847
[6]   LACK OF BENEFIT OF METHOTREXATE IN SEVERE, STEROID-DEPENDENT ASTHMA - A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY [J].
ERZURUM, SC ;
LEFF, JA ;
COCHRAN, JE ;
ACKERSON, LM ;
SZEFLER, SJ ;
MARTIN, RJ ;
COTT, GR .
ANNALS OF INTERNAL MEDICINE, 1991, 114 (05) :353-360
[7]   An evaluation of colchicine as an alternative to inhaled corticosteroids in moderate asthma [J].
Fish, JE ;
Peters, SP ;
Chambers, CV ;
McGeady, SJ ;
Epstein, KR ;
Boushey, HA ;
Cherniack, RM ;
Chinchilli, VM ;
Drazen, JM ;
Fahy, JV ;
Hurd, SS ;
Israel, E ;
Lazarus, SC ;
Lemanske, RF ;
Martin, RJ ;
Mauger, EA ;
Sorkness, C ;
Szefler, SJ .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1997, 156 (04) :1165-1171
[8]   Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol [J].
Kalra, S ;
Swystun, VA ;
Bhagat, R ;
Cockcroft, DW .
CHEST, 1996, 109 (04) :953-956
[9]  
KANE GC, 1994, CLIN PULM MED, V1, P69
[10]   EFFECTS OF COLCHICINE ON IGE-MEDIATED EARLY AND LATE AIRWAY REACTIONS [J].
KELLY, SJ ;
URI, AJ ;
FREELAND, HS ;
WOODS, EJ ;
SCHULMAN, ES ;
PETERS, SP ;
FISH, JE .
CHEST, 1995, 107 (04) :985-991